In the late-stage MajesTEC-3 trial, Tecvayli plus the subcutaneous formulation of J&J’s antibody drug Darzalex beat ...
MedPage Today on MSN
CAR-T Drug for Myeloma Hit With New Boxed Warning
Ciltacabtagene autoleucel (cilta-cel; Carvykti) for multiple myeloma has a new boxed warning for immune effector ...
Tecvayli combined with Darzalex Faspro improves overall survival in relapsed/refractory multiple myeloma, Johnson & Johnson ...
The triplet regimen of berdomide, daratumumab (Darzalex), and dexamethasone has led to deepening responses in newly diagnosed, transplant-ineligible patients with multiple myeloma.
Researchers at UMC Utrecht have discovered that converting monoclonal antibodies from the IgG to the IgM isotype can ...
MedPage Today on MSN
Myeloma Drug Performs Well in Autoimmune Diseases
Novel therapies for certain autoimmune diseases have been developed to end B cell-driven immune attacks on normal tissues.
Binod Dhakal, MD, associate professor of medicine in the Division of Hematology at the Medical College of Wisconsin, ...
Oncopeptides AB ( ($SE:ONCO) ) has issued an update. Oncopeptides AB announced the publication of three case reports in the Journal of Cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback